This is what I don’t understand? If it’s good news with Angleman? Then we have another good drug in the very near future looking\seeming positive? Why are we trading so low from our days at $25? Was Neu overpriced at $25? Because it feels a no brainer for people wanting to take a punt on a good company! Should say a decent investment opportunity for anyone taking notice. Yer I know I’m just banging on about what we all know. But it just feels strange that Neu has hit every thing out of the park so far.
Ann: Trading Halt, page-37
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
0.080(0.62%) |
Mkt cap ! $1.664B | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.35 | $12.99 | $5.557M | 423.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1588 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.06 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |